Marshall Wace Portfolio holdings
Marshall Wace is a British firm that runs long/short hedge funds. Its strategies combine computer-driven and traditional company analysis, applied worldwide and mostly to long/short equity. Paul Marshall, formerly head of European equities at Mercury Asset Management, and Ian Wace, formerly head of equities trading at Deutsche Bank, founded it in 1997. In 2002 it launched TOPS, a system that gathers investment ideas from equity professionals and uses algorithms to turn them into stock portfolios. In 2015 Marshall Wace formed a long-term partnership with KKR, a private equity and credit investor that took an ownership interest in the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Embotelladora Andina Series B
AKO.B
$4.44B
| – | – |
-11,562
| Closed | -$292K | – |
|
3102
DELISTED
Air Lease Corp
AL
| – | – |
-281,544
| Closed | -$18.3M | – |
|
3103
CALL
Align Technology
ALGN
$10.6B
| – | – |
-1,600
| Closed | -$274K | – |
|
|
3104
Align Technology
ALGN
$10.6B
| – | – |
-69,842
| Closed | -$12M | – |
|
|
3105
PUT
Align Technology
ALGN
$10.6B
| – | – |
-2,000
| Closed | -$343K | – |
|
3106
Allstate
ALL
$65.7B
| – | – |
-156,000
| Closed | -$32.3M | – |
|
3107
Ally Financial
ALLY
$11.6B
| – | – |
-620,108
| Closed | -$24.3M | – |
|
3108
Alto Ingredients
ALTO
$283M
| – | – |
-3,337,356
| Closed | -$16.2M | – |
|
3109
Autoliv
ALV
$8.46B
| – | – |
-6,899
| Closed | -$725K | – |
|
3110
CALL
Ambarella
AMBA
$2.79B
| – | – |
-800
| Closed | -$41.2K | – |
|
|
3111
Ambarella
AMBA
$2.79B
| – | – |
-249,542
| Closed | -$12.8M | – |
|
|
3112
PUT
Ambarella
AMBA
$2.79B
| – | – |
-1,900
| Closed | -$97.8K | – |
|
3113
PUT
Amgen
AMGN
$252B
| – | – |
-100
| Closed | -$35.2K | – |
|
3114
Amkor Technology
AMKR
$9.8B
| – | – |
-6,225
| Closed | -$280K | – |
|
3115
AmpliTech
AMPG
$79.5M
| – | – |
-14,442
| Closed | -$27.4K | – |
|
3116
Ameresco
AMRC
$1.08B
| – | – |
-87,176
| Closed | -$2.22M | – |
|
3117
AN2 Therapeutics
ANTX
$171M
| – | – |
-17,700
| Closed | -$60.5K | – |
|
3118
Artivion
AORT
$1.1B
| – | – |
-56,009
| Closed | -$2.05M | – |
|
3119
APA Corp
APA
$18.5B
| – | – |
-70,604
| Closed | -$3M | – |
|
3120
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-929,019
| Closed | -$37.4M | – |
|
3121
PUT
Applovin
APP
$76.5B
| – | – |
-132,000
| Closed | -$52.5M | – |
|
3122
Aptiv
APTV
$9.12B
| – | – |
-36,653
| Closed | -$2.55M | – |
|
3123
CALL
Antero Resources
AR
$12.9B
| – | – |
-700
| Closed | -$29.7K | – |
|
|
3124
PUT
Antero Resources
AR
$12.9B
| – | – |
-1,700
| Closed | -$72.1K | – |
|
3125
Accuray
ARAY
$16.7M
| – | – |
-68,751
| Closed | -$26.8K | – |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.